Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis. - Wikidata - wikimedia - TriplyDB

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.

http://www.wikidata.org/entity/Q34642604

about

Pathogenesis, management and prevention of atypical femoral fractures Do bisphosphonates cause femoral insufficiency fractures?Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects Synchrotron Imaging Assessment of Bone Quality Novel advances in the treatment of osteoporosis.The effect of antiresorptives on bone quality.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation.Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club Potential pathophysiological mechanisms in osteonecrosis of the jaw.Collagen mutation causes changes of the microdamage morphology in bone of an OI mouse model Is surgery necessary for femoral insufficiency fractures after long-term bisphosphonate therapy?Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.Bisphosphonates and atypical fractures of femur.Diseases affecting bone quality: beyond osteoporosis.Bone microdamage, remodeling and bone fragility: how much damage is too much damage?Age-related differences in the morphology of microdamage propagation in trabecular bone.Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women Research perspectives: The 2013 AAOS/ORS research symposium on Bone Quality and Fracture Prevention.Density and architecture have greater effects on the toughness of trabecular bone than damage.Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.Bisphosphonates and atypical subtrochanteric fractures of the femur.Use of bisphosphonates in the management of postmenopausal osteoporosis.Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues.Current options for the management of postmenopausal osteoporosis.Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.Review: epidemiology and pathophysiology of atypical femur fractures.Pharmacology of Bisphosphonates in Patients with Chronic Kidney Disease.Odanacatib for the treatment of osteoporosis.Treatment of Osteoporosis with Antiresoptive agent, Alendronate - warrants careful follow-up.Bone micromechanical properties are compromised during long-term alendronate therapy independently of mineralization.The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density.Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women.Three years of alendronate treatment does not continue to decrease microstructural stresses and strains associated with trabecular microdamage initiation beyond those at 1 year.Methodological approach for the detection of both microdamage and fluorochrome labels in ewe bone and human trabecular bone.Cortical bone quality affectations and their strength impact analysis using holographic interferometry

P2860

Q26824555-33EFF4B3-B165-4620-96B9-54104C708FA9 Q27021396-6FFB98D1-68F9-4109-936B-994373DD68F4 Q27025945-D63167EE-94E4-422A-9024-C46A4A2BCD65 Q28075733-48FA5F7E-0335-46FD-96E2-E12A416AACA5 Q30248319-2D4518DC-7C0F-44AA-A0F7-33912944EA88 Q33896122-B6CC16A7-C500-4B42-8014-083656672C3D Q34018048-1949B5A5-5E33-4480-A829-76BADC7F00B4 Q34053936-8D07559A-A3A3-470E-A2BB-308C3951629E Q34099162-C43FEB90-612F-4C96-9D2B-981CE9C6F384 Q34162359-CD99BB56-771F-4703-9451-8E721B1AD08F Q34268022-A6946D66-FD09-4BC9-B22B-B9B9915488F3 Q34283772-0F18489E-1B90-4ADD-BF92-2589BEE9E407 Q34395462-00F8EE1D-4104-46D4-B603-184F365B8C85 Q34986933-0BFDB374-55EA-4B39-B663-CF67955847A0 Q35078847-60EC422D-9F9A-44B3-A316-E024159881AD Q35211086-3453E1C2-0FC1-4433-8AF9-AE3EE2C35ACB Q35291434-D322C8CC-3E4D-42F5-9FE1-7028C4C3EA27 Q35566438-5209D450-3AF0-4A17-BA96-0AA02875EC44 Q35598005-882D2A8C-CD12-4410-A07D-C8382744EAB9 Q36117213-49B1FC9E-FD65-4F5D-8DF9-C86395E0DAAD Q36473294-545A3DA0-CACE-4326-B43E-C1EC970DC8F3 Q37352318-D9D3B838-7BC8-4972-94B4-0230FF6BD506 Q37682081-E51B00ED-F570-4F78-B944-FF9D6C10505A Q37733851-ADC55E69-6A57-43BF-8AF7-65671AC545BD Q37800181-EDB841F8-CA08-4084-BDFC-610991374F15 Q37812618-E8D0616E-AC34-4519-B269-5517CD4CF69F Q37931985-30D50661-9A41-4424-97ED-A7299B22B896 Q37945476-5B3DA090-1B14-403C-8938-BC3C25F7BA5E Q38187901-A9681D30-673C-48C9-8F7D-7067A5C9A868 Q38458773-216DFE0D-5BAD-4E32-B602-6F6BEF5884EC Q38543387-38BC8706-C1FD-4A8F-BC51-5B2A8BA7E49C Q39703171-6C311C9E-5F5B-4D9C-9704-B517DBADB141 Q46292054-3318ABA2-8441-4605-8DF3-18525F435719 Q47119987-1A990D13-E034-4689-A217-B6F1E7248AEB Q48265576-BB8CB344-86B2-4BEA-B8CB-35FEA30FC7C4 Q50504521-E4EC212C-5202-4FF2-8EDD-8A3EADECD40C Q50516899-708BBCDF-5BB8-4184-9C3A-74561805FDD5 Q57493454-A1827860-BB4D-4299-A531-AE5874DC9E54

P2860

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.

http://www.wikidata.org/entity/Q34642604

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Low bone mineral density is as ...... ausal women with osteoporosis.

@ast

Low bone mineral density is as ...... ausal women with osteoporosis.

@en

Low bone mineral density is as ...... ausal women with osteoporosis.

@nl

type

label

Low bone mineral density is as ...... ausal women with osteoporosis.

@ast

Low bone mineral density is as ...... ausal women with osteoporosis.

@en

Low bone mineral density is as ...... ausal women with osteoporosis.

@nl

prefLabel

Low bone mineral density is as ...... ausal women with osteoporosis.

@ast

Low bone mineral density is as ...... ausal women with osteoporosis.

@en

Low bone mineral density is as ...... ausal women with osteoporosis.

@nl

P1433

Q34642604-BFE1A3CE-0F9C-47D7-884C-3C9AA3634394

P1476

Q34642604-A056A823-70F3-4C82-939A-5916CCC18911

P2093

Q34642604-0A5E6427-C12F-4F3E-BDC7-C8FEB952B32B

Q34642604-3BA8B546-0774-4F49-B8EF-D7C01C490024

Q34642604-4FDE5544-A364-42BE-80F2-52C321B2099A

Q34642604-5F69E1BD-6E33-4EEE-9977-01C410FC3CEC

Q34642604-5FCDDFF1-28B6-489B-BEF9-AE1819F48AF9

Q34642604-62D8F6CD-B66F-491B-8C5C-3679F91E2FFC

Q34642604-AE4E8C22-60D3-4369-AE74-D1BF07D746E3

Q34642604-AF24FF0E-E229-48CF-9166-611F2F95F9A3

Q34642604-B5C4B78E-5AFC-4449-AD17-B96DADD2E8D6

Q34642604-CD7ED904-7390-494E-929B-373DD311993B

P304

Q34642604-5E970DC8-338A-4816-BF83-276A302492AA

P31

Q34642604-3ED8AE74-0B8A-4FAF-942D-01A050F4EBA1

P356

Q34642604-0D8B3599-1967-4F44-9D32-23D8B1630D46

P433

Q34642604-A1602919-9819-4D0D-9FA6-A07B7E945427

P478

Q34642604-497AB1A3-B767-46C5-B236-E1810B4F31EE

P577

Q34642604-2195ADD4-741C-47FA-AF9F-E92AC6DEA53A

P5875

Q34642604-41ABF7E6-4EB6-4595-9898-8D9C8504A240

P698

Q34642604-F90513DB-FFCC-4409-A096-72845C3E78FF

P921

Q34642604-03180701-D05A-4D99-8534-7B8B737C29FF

P356

J.BONE.2007.04.198

P1433

P1476

Low bone mineral density is as ...... ausal women with osteoporosis.

@en

P2093

Adrien Sipos

http://www.w3.org/2001/XMLSchema#string

Astrid Fahrleitner-Pammer

http://www.w3.org/2001/XMLSchema#string

Dana Michalska

http://www.w3.org/2001/XMLSchema#string

David B Burr

http://www.w3.org/2001/XMLSchema#string

David Michalsky

http://www.w3.org/2001/XMLSchema#string

Harald Dobnig

http://www.w3.org/2001/XMLSchema#string

Helmut Petto

http://www.w3.org/2001/XMLSchema#string

Imre Pavo

http://www.w3.org/2001/XMLSchema#string

Jan J Stepan

http://www.w3.org/2001/XMLSchema#string

Jiliang Li

http://www.w3.org/2001/XMLSchema#string

P304

378-385

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BONE.2007.04.198

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2007-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6240555

http://www.w3.org/2001/XMLSchema#string

P698

17597017

http://www.w3.org/2001/XMLSchema#string

P921